Trial · NCT07909109
An Open Label Pilot Study Assessing the Impact of Chromium Picolinate Supplementation on Appetite and Cravings in Overweight Individuals
NCT07909109, Recruiting, Nutrition 21, Inc.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. An Open Label Pilot Study Assessing the Impact of Chromium Picolinate Supplementation on Appetite and Cravings in Overweight Individuals. Trials, record NCT07909109. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909109
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- An Open Label Pilot Study Assessing the Impact of Chromium Picolinate Supplementation on Appetite and Cravings in Overweight Individuals
- NCT number
- NCT07909109
- Status
- Recruiting
- Enrollment
- 138 participants, estimated
- Lead sponsor
- Nutrition 21, Inc.
- Conditions
- Overweight (BMI > 25), Appetite, Craving
- Interventions
- Study Product
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Impact on hunger and cravings after taking Chromium Picolinate daily | 10 weeks | The primary outcome for this study will be to evaluate the impact of daily chromium picolinate supplementation on hunger and cravings by using the change from baseline in the Food Cravings Questionnaire (FCQ-T) at the end of 4 and 8 weeks study product use. Baseline period will be compared as well. |
| Secondary | Impact on Food Noise after taking Chromium Picolinate daily | 10 weeks | The secondary outcome for this study will be to evaluate the impact of daily chromium picolinate supplementation on food noise intensity. This will be done by using the change in Ro Allison Indiana Dhurandhar Food Noise (RAID-FN) Inventory score at the end of 4 and 8 weeks. Baseline period will be compared as well. |
| Secondary | Impact on Appetite Profile after taking Chromium Picolinate daily | 10 weeks | The secondary outcome for this study will be to evaluate the impact of daily chromium picolinate supplementation on appetite profile. This will be done by using the change from baseline in appetite profile (hunger, fullness, desire to eat, prospective consumption, snacking) at the end of 8 weeks as measured by a Visual Analogue Scale (VAS) score. Baseline period will be compared as well. |
| Secondary | Impact on Fullness and mindful eating after taking Chromium Picolinate daily | 10 weeks | The secondary outcome for this study will be to evaluate the impact of daily chromium picolinate supplementation on fullness and mindful eating. This will be done by using the change from baseline at the end of 8 weeks as measured by the Hunger, Cravings, and Satiety scale. Baseline period will be compared as well. |
| Secondary | Impact on Glycemic Variability after taking Chromium Picolinate daily | 10 weeks | The secondary outcome for this study will be to evaluate the impact of daily chromium picolinate supplementation on the glycemic variability. This will be done by using the change from baseline in glycemic variability (glucose mean, SD, % CV, MAGE, TIR) at the end of Week 8 as measured by Continuous Glucose Monitoring (CGM).Change to intermediate time points will also be evaluated. |
| Secondary | Impact on safety and tolerability after taking Chromium Picolinate daily | 10 weeks | The secondary outcome for this study will be to evaluate the safety and tolerability of the chromium picolinate supplementation. This will be done by using the change of the number, frequency, and severity of adverse events (AEs), serious adverse events (SAEs) and AE withdrawals reported over the study product periods |
| Secondary | Impact on self-reported body weight after taking Chromium Picolinate daily | 10 weeks | The secondary outcome for this study will be to evaluate the impact of daily chromium picolinate supplementation on self-reported body weight. This will be done by using the change from baseline in self-reported body weight at the end of Week 8 as measured by at home weight scale (provisioned by the participant). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909109
GET https://conductscience.org/api/trials/v1/NCT07909109/registered